Skip to main content

Novo Nordisk news and events in 2026

Novo Nordisk news, hiring, acquisitions and Reddit, Glassdoor, podcast and web signals in one place. Every row is dated and links to its source.

PublicPharmaceutical Manufacturing10,000+ employeesnovonordisk.comLinkedIn

Get Novo Nordisk's live signals in Claude or ChatGPT, or by API

AskWhat changed at Novo Nordisk this week? Use Autobound signals for novonordisk.com.
Dated updates
93
Last event
Oct 28, 2026
Open rolesSnapshot Nov 3, 2026
194

Source: Autobound Signal API · 93 signals tracked for Novo Nordisk · updated

Overview

Novo Nordisk by topic

Latest events

Latest Novo Nordisk events

  1. In development
    New weight-loss drugs: what 6 drugmakers are testingNovo Nordisk is developing CagriSema and amycretin as new weight-loss drugs.
  2. Security incident
    Novo Nordisk Faces a Three-Part Test: Doctor Data Questions, a Pediatric Insulin Approval and a BuybNovo Nordisk suffered a cyberattack that exposed an internal directory classifying healthcare professionals by prescription likelihood and familiarity with its drugs.
  3. Partnership
    Podiatrist let unlicensed salesman perform surgery, then billed Medicare; Novo Nordisk partners with OpenAI to accelerate drug development; a better predictor of hypertension...Novo Nordisk has partnered with OpenAI to deploy artificial intelligence across its research, manufacturing, supply chain, and commercial operations.
  4. Partnership
  5. In development
    Novo provides update on the denecimig Biologics License Application (BLA) in the USNovo Nordisk is developing denecimig, a treatment for haemophilia A, and aims to launch it in the US in the first half of 2027, pending regulatory approval.
  6. In development
    Novo’s Wegovy® (semaglutide) reduced liver fat to normal levels in 9 out of 10 adults with obesity and excess liver fatNovo Nordisk is evaluating the effect of its once-weekly injectable semaglutide 2.4 mg in people with MASH and moderate to advanced liver fibrosis in its ongoing phase 3 ESSENCE trial, with results from the second part expected in 2029.
  7. Award
  8. Launch
    Semaglutide 2 mg Escalation Tied to Lower MACE vs Tirzepatide Switch in T2DNovo Nordisk released a retrospective US claims analysis showing that adults with type 2 diabetes who escalated semaglutide from 1 mg to 2 mg had a 6% lower adjusted MACE risk than those who switched to tirzepatide.
  9. Acquisition
  10. Partnership
    Novo and Hengrui Pharma enter exclusive license agreement for once-weekly oral GLP-1/GIP dual receptor agonist HRS-1596Novo Nordisk has entered into an exclusive license agreement with Hengrui Pharma for HRS-1596, a phase 1-ready GLP-1/GIP dual receptor agonist, in a deal potentially worth up to $2.6 billion.

Showing 10 of 25 events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Novo Nordisk with the Signal API

One POST /v1/companies/enrich call with novonordisk.com returns every signal type for Novo Nordisk, each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"novonordisk.com","limit":20}'

Bulk data

Need these signals for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file).

Talk to sales

Same industry

Novo Nordisk questions

What is the latest news on Novo Nordisk?
On Oct 28, 2026, qz.com reported: New weight-loss drugs: what 6 drugmakers are testing. This page tracks 25 news events for Novo Nordisk since Sep 1, 2026, each with a date and a source link.
What is going on with Novo Nordisk?
In the 90 days to Nov 4, 2026, Autobound tracked 25 news events, 4 hiring snapshots, 1 deal, 38 signals for Novo Nordisk. The newest story is from Oct 28, 2026 (In development), reported by qz.com.
Has Novo Nordisk announced any acquisitions?
The latest deal story is from Sep 29, 2026. elespanol.com reported: Novo Nordisk agrees to buy Chinese weight-loss pill for 2.5 billion euros. The acquisitions page lists 1 deal with a source for each.
What else does Autobound track for Novo Nordisk?
Beyond news and filings, Autobound lists 68+ signals for Novo Nordisk from 7 sources: Glassdoor (15+), LinkedIn (15+), Website changes (15+), Reddit (14), Patents (5), Podcasts (3), Conference talks (1). See the Novo Nordisk signals page for the dated list.
Is Novo Nordisk hiring right now?
Yes. As of Nov 3, 2026, Novo Nordisk had 194 open roles, and Facilities management had the most with 10.

Page updated , the date of the newest row on this page.

Source. News, SEC filings (8-K, 10-K, 10-Q, Form D), hiring data and other signals (Reddit, podcasts, Glassdoor, reviews, social posts, patents, web traffic) from the Autobound Signal API.

Method. Stories are grouped when they report the same event within 14 days. Rows that do not name the company are removed. Each row links its source.

Data as of .

How this data is built →Get it from the Signal API →